MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer is a leading cause of cancer-related deaths globally, with metastasis and recurrence being primary drivers.
• MicroRNAs (miRNAs) are crucial regulators of cellular processes, including cancer metastasis.
• The specific role of miR-128 in breast cancer progression remained largely unexplored.

Purpose of the Study:

• To investigate the function of miR-128 in breast cancer.
• To identify the molecular targets of miR-128 involved in breast cancer metastasis.
• To evaluate the potential of miR-128 as a biomarker and therapeutic target.

Main Methods:

• Quantitative analysis of miR-128 expression in human breast cancer tissues and cell lines.
• Functional assays assessing cell motility and invasion upon miR-128 modulation.
• Target gene identification using bioinformatics and experimental validation.
• Western blot analysis to confirm protein expression levels of MTDH.

Main Results:

• miR-128 expression was significantly downregulated in breast cancer tissues and inversely correlated with histological grade.
• Ectopic expression of miR-128 suppressed breast cancer cell migration and invasion.
• Metadherin (MTDH) was identified as a direct target of miR-128, with MTDH expression upregulated in clinical samples.
• MTDH knockdown inhibited cell invasion, while its re-expression counteracted the suppressive effects of miR-128.

Conclusions:

• miR-128 plays a tumor-suppressive role in breast cancer by inhibiting metastasis.
• The miR-128/MTDH axis is a critical regulator of breast cancer cell invasion and motility.
• miR-128 holds promise as a novel biomarker for predicting breast cancer metastasis and as a potential therapeutic target.